After a rigorous review process, three projects have been selected to receive support to engage in a planning process to further develop the proposed research. Projects address questions of Translational Science, defined by NIH National Center for Advancing Translational Science (NCATS), as projects that focus on the common causes of inefficiency and failure in translational research projects. The selected projects will be submitted as part of the ICTS suite of applications to the NIH NCATS in May of 2023.
Congratulations to the recipients!
Interdisciplinary and translational research in cancer-related cognitive impairment
The proposed studies will dive deep into the neurobiological underpinnings of radiation- and chemotherapy- neuroprotective effects of BDNF against various forms of cognitive impairment associated with cancer treatment modalities (such as chemotherapy, radiation, and immunotherapy).
SAFER (Standardizing Assessment For Effective Response) Lines and Wounds Mobile Applications at Home to Reduce Infection
The approach of this study is generalizable to any medical illness with discrete symptoms or visible signs that can be captured by photographs. The catalytic potential of this work includes advances in the monitoring of complex medical care at home by creating and evaluating the interface between patient, provider, and AI technology and advances in infection prevention research through the creation of a regional healthcare-associated infections database for other researchers to efficiently study this unique group of patients.
Redefining Antimicrobial Susceptibility Testing Under Physiological Conditions for Multidrug-Resistant Pathogens
This proposal presents a coordinated, strategic research plan to improve the health of all individuals worldwide by revamping our assessments of in vitro antibiotic efficacy. The knowledge gained herein has the potential for immediate translational impact by overcoming a significant roadblock in the evaluation of antibiotic activity to shift paradigms that will save lives.
Additional Collaborators: Jon Monk, PhD; David González, PhD; Warren Rose, PharmD
